|
2023
|
Invention
|
Modified coronavirus s protein. The present disclosure relates to modified coronavirus S protein ... |
|
2022
|
Invention
|
Modified influenza b virus hemagglutinin. The present disclosure relates to the production of mod... |
|
|
Invention
|
Recombinant influenza virus-like particles (vlps) produced in transgenic plants.
A method for sy... |
|
|
G/S
|
Wholesale store services featuring pharmaceuticals, pharmaceutical ingredients, vaccines, therape... |
|
|
G/S
|
Manufacture of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins ... |
|
|
G/S
|
Pharmaceutical and medicinal preparations and substances, namely, human vaccines, therapeutic pro... |
|
2021
|
Invention
|
Cpmv vlps displaying sars-cov-2 epitopes. The present disclosure relates to the production of mod... |
|
|
Invention
|
Modified coronavirus structural protein.
Modified coronaviras spike (S)-protein, virus-like part... |
|
|
Invention
|
Modified coronavirus structural protein. Modified coronaviras spike (S)-protein, virus-like parti... |
|
|
Invention
|
Influenza virus-like particle production in plants.
A method of producing a virus like particle ... |
|
|
G/S
|
Human vaccines for preventing and treating coronaviruses diseases and disorders |
|
|
G/S
|
Human vaccines. |
|
|
G/S
|
Human vaccines. |
|
|
Invention
|
Suprastructure comprising modified influenza hemagglutinin with reduced interaction with sialic a... |
|
|
G/S
|
Vaccines for human use. |
|
2020
|
Invention
|
Nicotiana benthamiana plant or cell with reduced xylt and fuct. Nicotiana varieties) that are sui... |
|
|
G/S
|
Human vaccines for treatment and prevention of coronaviruses |
|
|
Invention
|
Virus like particle production in plants.
A method of producing a virus like particle (VLP) in a... |
|
|
G/S
|
Human vaccines |
|
|
G/S
|
Human vaccines |
|
|
G/S
|
Human vaccines for the prevention and treatment of SARS-COV2, COVID-19, and coronavirus diseases ... |
|
|
Invention
|
Rotavirus vp7 fusion proteins and rotavirus-like particles comprising them.
Nucleic acids encodi... |
|
|
Invention
|
Rotavirus vp7 fusion proteins and rotavirus-like particles comprising them. Nucleic acids encodin... |
|
|
G/S
|
Pharmaceutical and medicinal preparations and substances namely human vaccines, therapeutic prote... |
|
2019
|
G/S
|
Pharmaceutical and medicinal preparations and substances
namely human vaccines, therapeutic prot... |
|
|
G/S
|
Human influenza vaccine |
|
|
G/S
|
Human influenza vaccine |
|
|
G/S
|
Influenza vaccines for human use. |
|
|
G/S
|
Human influenza vaccines |
|
|
Invention
|
Influenza virus hemagglutiniin mutants.
The present invention relates to the production of modif... |
|
|
Invention
|
Influenza virus hemagglutinin mutants. The present invention relates to the production of modifie... |
|
|
Invention
|
Endogenous plant expression enhancer. An isolated expression enhancer active in a plant, portion ... |
|
|
Invention
|
Plant expression enhancer. An isolated expression enhancer active in a plant, portion of a plant ... |
|
2018
|
Invention
|
Picornavirus-like particle production in plants. A method of producing a picornavirus-like partic... |
|
|
Invention
|
Modified norovirus vp1 proteins and vlps comprising modified norovirus vp1 proteins. Nucleic acid... |
|
|
G/S
|
Pharmaceutical and medicinal preparations and substances namely therapeutic proteins and antibodi... |
|
|
G/S
|
Human influenza vaccine. |
|
|
Invention
|
Norovirus fusion proteins and vlps comprising norovirus fusion proteins. Nucleic acids encoding n... |
|
2017
|
Invention
|
Modifying n-glycosylation of plant proteins using gdp-4-dehydro-6-deoxy-d-mannose reductase (rmd)... |
|
2016
|
Invention
|
Jasmonic acid pathway activator. A method of increasing expression of an heterologous protein of ... |
|
|
Invention
|
Rotavirus-like particle production in plants. A method of producing a rotavirus-like particle (RL... |
|
2015
|
Invention
|
Modifying protein production in plants. A method for synthesizing a protein of interest within a ... |
|
|
Invention
|
Modified cpmv enhancer elements. An expression enhancer comprising, in series, a CPMV 5′UTR nucle... |
|
|
Invention
|
Modified cpmv enhancer elements. An expression enhancer comprising, in series, a CPMV 5'UTR nucle... |
|
|
Invention
|
Cpmv enhancer elements. An expression enhancer comprising a CPMV 5'UTR nucleotide sequence consis... |
|
2013
|
Invention
|
Method for making nicotiana plants with mutations in xylt and fuct alleles using rare-cutting end... |
|
|
Invention
|
Rotavirus-like particle production in plants.
A method of producing a virus-like particle (VLP) ... |
